Tentes, Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature, Int. J. Hyperther. 31 (2015) 850e856, https://doi.org/10.3109/ 02656736.2015.1075071....
Tumor-Treating Fields (TTFields) use intermediate-frequency and low-intensity electric fields to inhibit tumor cells. However, their mechanisms are still not well understood. This article reviews their key antitumor mechanisms at the cellular and molecular levels, including inhibition of proliferation, in...
Banner Professor of Thoracic Oncology, Vice-Chair Research, Department of Cardiothoracic Surgery, Division Chief, General Thoracic Surgery, NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma. Mesothelioma is a notorious disease of elderly people, Pass says, and sym...
Only about 20% of patients with mesothelioma are good surgical candidates for multimodality treatment It is important to find the disease early, when effective therapies may have a chance Interviews | LUNG CANCER | EGFR+ Lung Cancer | Biomarker-Driven Lung Cancer ...
Patients with lung cancer and mesothelioma may undergo a host of treatment options, including surgery, radiation therapy and chemotherapy. For early stage mesothelioma patients, Fox Chase takes an individualized surgical approach tailored to the patient’s overall health and other important factors. Surge...
Commentwww.thelancet.com/oncology Vol 20 December 2019 1623The challenge of improving standard-of-care chemo-therapy with pemetrexed and cisplatin for mesothelioma has proven to be virtually insurmountable since 2004. The addition of novel agents to standard chemotherapy in phase 3 trials has not suc...
The FDA has designated the TTFields delivery system as a humanitarian use device for the treatment of pleural mesothelioma. Patients remain at the heart of the work at Novocure, guiding us forward in our goal to deliver a novel, safe and efficacious cancer therapy that prolongs survival while ...
(TTFields)—an approach in which alternating electrical fields exert biophysical force on charged and polarisable molecules known as dipoles—to standard therapy, has been shown to extend survival for patients with newly diagnosed GBM, recurrent GBM and mesothelioma, leading to the clinical approval ...
OA22.01 STELLAR - interim results of a phase 2 trial of TTFields with chemotherapy for first line treatment of malignant mesothelioma J. Thorac. Oncol., 12 (S329) (2016) Google Scholar [23] T. Voloshin, et al. Alternating electric fields (TTFields) in combination with paclitaxel are therape...
37. The method of claim 36, wherein the tumor cells are selected from the group consisting of fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, chordoma, angiosarcoma, endotheliosarcoma, lymphangiosarcoma, lymphangioendotheliosarcoma, synovioma, mesothelioma, Ewing's tumor, le...